DK2097079T3 - Modulering af prostaglandin/cyclooxygenase-metabolske veje - Google Patents
Modulering af prostaglandin/cyclooxygenase-metabolske vejeInfo
- Publication number
- DK2097079T3 DK2097079T3 DK07870407.9T DK07870407T DK2097079T3 DK 2097079 T3 DK2097079 T3 DK 2097079T3 DK 07870407 T DK07870407 T DK 07870407T DK 2097079 T3 DK2097079 T3 DK 2097079T3
- Authority
- DK
- Denmark
- Prior art keywords
- prostaglandin
- modulation
- metabolic pathways
- cyclooxygenase
- cyclooxygenase metabolic
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86787306P | 2006-11-30 | 2006-11-30 | |
GB0623971A GB0623971D0 (en) | 2006-11-30 | 2006-11-30 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
PCT/GB2007/004584 WO2008065408A2 (en) | 2006-11-30 | 2007-11-29 | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2097079T3 true DK2097079T3 (da) | 2012-10-01 |
Family
ID=37671641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07870407.9T DK2097079T3 (da) | 2006-11-30 | 2007-11-29 | Modulering af prostaglandin/cyclooxygenase-metabolske veje |
Country Status (9)
Country | Link |
---|---|
CN (1) | CN101594861B (es) |
DK (1) | DK2097079T3 (es) |
ES (1) | ES2390182T3 (es) |
GB (1) | GB0623971D0 (es) |
NZ (1) | NZ577075A (es) |
PT (1) | PT2097079E (es) |
RS (1) | RS52453B (es) |
RU (1) | RU2448712C2 (es) |
SI (1) | SI2097079T1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI713972B (zh) * | 2019-01-14 | 2020-12-21 | 大江生醫股份有限公司 | 改善呼吸道健康之益生菌株及其組合物與用途 |
TWI692359B (zh) * | 2019-02-25 | 2020-05-01 | 大江生醫股份有限公司 | 乳酸菌的代謝產物及其用於護肺的用途 |
CN111777613A (zh) * | 2019-04-03 | 2020-10-16 | 中国药科大学 | 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途 |
CN113905732A (zh) * | 2019-04-09 | 2022-01-07 | 纽罗比特科学有限公司 | 用于预防或治疗脊髓损伤或椎管狭窄的药物组合物 |
CN111394289B (zh) * | 2019-12-20 | 2021-06-11 | 合肥康诺生物制药有限公司 | 一种基因工程菌及其应用,生产前列腺素e2的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2363984A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids |
GB2363983A (en) * | 2000-06-29 | 2002-01-16 | Hunter Fleming Ltd | Protection against neuronal damage using 7-hydroxyepiandrosterone |
GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
FR2829697B1 (fr) * | 2001-09-14 | 2004-03-19 | Mayoly Spindler Lab | Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin |
-
2006
- 2006-11-30 GB GB0623971A patent/GB0623971D0/en not_active Ceased
-
2007
- 2007-11-29 ES ES07870407T patent/ES2390182T3/es active Active
- 2007-11-29 RS RS20120372A patent/RS52453B/en unknown
- 2007-11-29 CN CN200780050499.5A patent/CN101594861B/zh not_active Expired - Fee Related
- 2007-11-29 PT PT07870407T patent/PT2097079E/pt unknown
- 2007-11-29 NZ NZ577075A patent/NZ577075A/en not_active IP Right Cessation
- 2007-11-29 DK DK07870407.9T patent/DK2097079T3/da active
- 2007-11-29 SI SI200731000T patent/SI2097079T1/sl unknown
- 2007-11-29 RU RU2009124917/15A patent/RU2448712C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101594861A (zh) | 2009-12-02 |
GB0623971D0 (en) | 2007-01-10 |
CN101594861B (zh) | 2013-06-12 |
RS52453B (en) | 2013-02-28 |
RU2009124917A (ru) | 2011-01-10 |
SI2097079T1 (sl) | 2012-10-30 |
RU2448712C2 (ru) | 2012-04-27 |
ES2390182T3 (es) | 2012-11-07 |
NZ577075A (en) | 2012-01-12 |
PT2097079E (pt) | 2012-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL350090I2 (nl) | flupyradifurone | |
DK2317851T3 (da) | Anvendelse af 5-fluorcytosin som fungicid | |
DK3225251T3 (da) | Modulering af pro-neurotrofinaktivitet | |
DK2111555T3 (da) | Diagnosticering af præeklampsi | |
DK2219469T3 (da) | Modificering af enzymatisk disponerede proteiner | |
DK3296284T3 (da) | Ikke-terapeutisk anvendelse af hydroxybutyratester | |
DK2269063T3 (da) | Forudsigelse af risiko for større uønskede hjertehændelser | |
DK2153565T3 (da) | Valg af transmissionsmodus | |
DK2180787T3 (da) | Nitrooliesyremodulering af type ii-diabetes | |
DK2187741T3 (da) | Hidtil ukendte former af cddo-methylester | |
DK2024504T4 (da) | Fremstilling af isoprenoider | |
DK1877568T4 (da) | Hydrolysering af arabinoxylan | |
DK3208269T3 (da) | Inhibitorer af c-fms-kinase | |
DK2371818T3 (da) | Hydroxybenzoatsalte af metanikotinforbindelser | |
DK2358714T3 (da) | Alkylcyclohexylethere af dihydrotetraazabenzoazulener | |
DK1986947T3 (da) | Installation af offshore-konstruktioner | |
BRPI0909448A2 (pt) | composição adesiva polimerizável | |
DK2700786T3 (da) | Modifikation af overførselspassage | |
DK2031948T3 (da) | Bestemmelse af en komponents brugstid | |
DK2117542T3 (da) | Kombinationer af beta-2-adrenoceptor-agonistisk benzothiazolon | |
DK2114147T3 (da) | Reduktion af bivirkninger af tramadol | |
DK1917227T3 (da) | Krystalformer af astaxanthin | |
DK2117732T3 (da) | Frembringelse af partier | |
DK2280962T5 (da) | Pyridazinonderivater | |
DK2083629T3 (da) | Krystallinsk modifikation af fipronil |